A critical advance in cancer research is occurring with the use of VHH fragments to re-engage damaged p53. This vital cancer protector protein is frequently lost in several types of malignancies, resulting uncontrolled https://tvsocialnews.com/story7596505/mini-antibodies-restore-tumor-suppressor-p53-a-new-pathway-for-malignant-management